PTEN is mislocalized and accumulated in the NFTs of AD patients leading to the inhibition of PI3 K and PP2 A. Intense immunolabeling was found in the large neurons, such as pyramidal cells, although reduced expression and redistribution of PTEN in the remaining neurons in AD. This evidence concerns the gene PTEN and Alzheimer disease.